Skip to main content
. 2017 Jun 8;12(6):e0178685. doi: 10.1371/journal.pone.0178685

Fig 1. Effects of the GCKR (rs780094) A mutation on hepatic steatosis A) and serum triglyceride levels B) in HIV-positive patients.

Fig 1

A: Liver fat assessed by the CAP parameter [dB/m] in GCKR (rs780094) wild type homozygous patients versus carriers of the GCKR (rs780094) A mutation. B: Levels of serum triglycerides [mg/dl] in wild type homozygous patients versus carriers of the GCKR (rs780094) A mutation. Box and whisker plots indicating medians, 10-, 25-, 75, and 90-percentiles as well as individual outliers.